TRINITY BIOTEC.ADR NEW A
TRINITY BIOTEC.ADR NEW A
Certificat de dépôt · US8964385046 · TRIB · A404JF (XNAS)
Aperçu
0,59 EUR
4,58 % 0,03 EUR
Frankfurt (XNAS) · Cours et graphiques actuels sur MoneyPeak
10.06.2025 16:34

Cours actuels de TRINITY BIOTEC.ADR NEW A

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
TRIB
USD
10.06.2025 16:34
0,68 USD
0,65 USD
+3,82 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
4,38 % 6,22 % -11,22 % -7,81 % -28,81 % -69,50 % -92,56 %

Profil de l'entreprise pour TRINITY BIOTEC.ADR NEW A Certificat de dépôt

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Données de l'entreprise

Nom TRINITY BIOTEC.ADR NEW A
Société Trinity Biotech plc
Symbole TRIB
Site web https://www.trinitybiotech.com
Marché d'origine XNAS Frankfurt
WKN A404JF
ISIN US8964385046
Type de titre Certificat de dépôt
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Mr. John Gillard
Pays Irlande
Devise EUR
Employés 0,4 T
Adresse IDA Business Park, A98 H5C8 Bray
Date d'introduction en bourse 1992-10-21

Changements d'identifiant

Date De À
30.06.2005 TRIBD TRIB

Symboles boursiers

Nom Symbole
Frankfurt TRB.F
NASDAQ TRIB

Autres actions

Les investisseurs qui détiennent TRINITY BIOTEC.ADR NEW A ont également les actions suivantes dans leur portefeuille :
CREDIT AGRICOLE CIB FINANCIAL SOLUTIONS IL INT & RED NTS 16/09/24
CREDIT AGRICOLE CIB FINANCIAL SOLUTIONS IL INT & RED NTS 16/09/24 Obligation
VALICA S.P.A.
VALICA S.P.A. Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025